Page last updated: 2024-12-08

scilliroside

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

scilliroside: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

scilliroside : A beta-D-glucoside that is scillirosidin in which the hydroxy group at position 3 is substituted by a beta-D-glucopyranoside group. It is a rodenticide extracted from the bulb of the Mediterranean squill plant and was used for the control of Norway rats, black rats, house mice, long-tailed field mice, and field voles. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID441871
SCHEMBL ID433422
MeSH IDM0079510

Synonyms (42)

Synonym
6-beta-(acetyloxy)-3-beta-(beta-d-glucopyranosyloxy)-8,14-dihydroxybufa-4,20,22-trienolide
brn 0074900
nsc 7523
3-beta,6-beta-6-acetyloxy-3-(beta-d-glucopyranosyloxy)-8,14-dihydroxybufa-4,20,22-trienolide
6beta-(acetyloxy)-3-beta-(beta-d-glucopyranosyloxy)-8,14-dihydroxybufa-4,20,22-trienolide
bufa-4,20,22-trienolide, 6-(acetyloxy)-3-(beta-d-glucopyranosyloxy)-8,14-dihydroxy-
3beta-(beta-d-glucopyropyanosyloxy)-6beta,8,14-trihydroxybufa-4,20,22-trienolide 6-accetate
caswell no. 722
scilliroside, (3beta,6beta)-
bufa-4,20,22-trienolide, 6-(acetyloxy)-3-(beta-d-glucopyranosyloxy)-8,14-dihydroxy-, (3beta,6beta)-
red squill
scillirosid
silmine
scillirosidin + glucose [german]
(3beta,6beta)-6-(acetyloxy)-3-(beta-d-glucopyranosyloxy)-8,14-dihydroxybufa-4,20,22-trienolide
einecs 208-077-4
epa pesticide chemical code 070801
scilliroside, (3-beta,6-beta)-
6beta-acetoxy-3beta(beta-d-glucopyranosyloxy)-8,14-dihydroxybufa-4,20,22-trienolide
silmurin
scillirosan
nsc-7523
squill
507-60-8
C08880
scilliroside
[(3s,6r,8s,9r,10r,13r,14r,17r)-8,14-dihydroxy-10,13-dimethyl-17-(6-oxopyran-3-yl)-3-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,6,7,9,11,12,15,16,17-decahydro-1h-cyclopenta[a]phenanthren-6-yl] acetate
hsdb 6733
6-beta-6-(acetyloxy)-3-beta-(beta-d-glocopyranosyloxy)-8,14-dihydroxybufa-4,20,22-trienolide
(3-beta,6-beta)scilliroside
2815004nho ,
3-beta,6-beta-6-acetyloxy-3-(beta-d-glocopyranosyloxy)-8,14-dihydroxybufa-4,20,22-trienolide
unii-2815004nho
4-18-00-03178 (beilstein handbook reference)
scillirosidin + glucose
SCHEMBL433422
bufa-4,20,22-trienolide, 6-(acetyloxy)-3-(.beta.-d-glucopyranosyloxy)-8,14-dihydroxy-, (3.beta.,6.beta.)-
[(3s,6r,8s,9r,10r,13r,14r,17r)-8,14-dihydroxy-10,13-dimethyl-17-(6-oxopyran-3-yl)-3-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-2,3,6,7,9,11,12,15,16,17-decahydro-1h-cyclopenta[a]phenanthren-6-yl] acetate
scilliroside [mi]
DTXSID5042374
(3s,6r,8s,9r,10r,13r,14r,17r)-8,14-dihydroxy-10,13-dimethyl-17-(2-oxo-2h-pyran-5-yl)-3-(((2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)oxy)-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-6-yl a
Q7433895
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
rodenticideA substance used to destroy rodent pests.
EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitorAn EC 3.6.3.* (acid anhydride hydrolase catalysing transmembrane movement of substances) inhibitor that interferes with the action of Na(+)/K(+)-transporting ATPase (EC 3.6.3.9).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
beta-D-glucosideAny D-glucoside in which the anomeric centre has beta-configuration.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (73.33)18.7374
1990's2 (13.33)18.2507
2000's2 (13.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 26.88

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index26.88 (24.57)
Research Supply Index2.94 (2.92)
Research Growth Index4.03 (4.65)
Search Engine Demand Index31.58 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (26.88)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (5.56%)6.00%
Case Studies1 (5.56%)4.05%
Observational0 (0.00%)0.25%
Other16 (88.89%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]